Telomir pharmaceuticals announces telomir-1 resets the body's epigenetic clock, reverses dna methylation, and restores youthful gene regulation in an ultra-rare accelerated aging animal model of werner syndrome

Treatment restored gene control, extended telomere length beyond healthy levels, reversed muscle and weight loss, reduced oxidative stress, and resulted in 100% survival - highlighting telomir-1's potential to reverse key hallmarks of aging miami, fl / access newswire / june 5, 2025 / telomir pharmaceuticals, inc. (nasdaq:telo), or the "company," an emerging leader in age-reversal science, today announced compelling new preclinical data demonstrating that its lead candidate, telomir-1, administered orally, significantly increases telomere length, reverses body weight and muscle loss, and resets cellular aging markers in a validated animal model of werner syndrome (ws)-a rare genetic disorder also known as adult-onset progeria. these findings confirm and build upon the company's previously reported results from a preclinical c.
DNA Ratings Summary
DNA Quant Ranking